Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More
August 17–21, 2025, Washington, DC, USA - Visit us at Booth 2230.
Read More
Email:
Phone:
Toggle navigation
Home
Services
ADC Linker Development
Chemically Cleavable Linker
Acid Cleavable Linker/Hydrazone Linker
Disulfide Linker
Enzyme Cleavable Linker
Cathepsin B Cleavable Linker/Peptide Linker
Phosphatase Cleavable Linker
Sulfatase Cleavable Linker
β-Galactosidase Cleavable Linker
β-Glucuronidases Cleavable Linker
Non-Cleavable Linker
ADC Payload Development
Biological Payload
Chemical Payload
DNA Damaging Agents
Microtubule Inhibitors
Protein Degraders
RNA Polymerase Inhibitors
Nanocarrier
Protein Toxin
ADC Manufacturing
ADC cGMP Manufacturing
ADC Fill/Finish
ADC Formulation Development
ADC Purification
ADC Linker–Payload Conjugation
Calicheamicin-Based Linker Conjugation
Deruxtecan-Based Linker Conjugation
MMAE/MMAF-Based Linker Conjugation
PBD-Based Linker Conjugation
SN-38-Based Linker Conjugation
Antibody Modification and Conjugation
Bispecific Antibody Conjugation
Carbohydrate Conjugation
Click Chemistry Conjugation
Cysteine Conjugation
Enzymatic Conjugation
Lysine Conjugation
Non-natural Amino Acids Conjugation
Site-Specific Conjugation
Thio-engineered Antibody
Tyrosine Conjugation
ADC Analysis and Characterization
In Vitro
Analysis
In Vivo
Analysis
ADC Bioanalysis
ADC Bioassay
ADME Analysis
DMPK Analysis
Drug Distribution Analysis
Drug-to-Antibody Ratio Analysis
Stability Analysis
ADC Development Platform
Antibody Fragment-Drug Conjugates (FDCs)
Bispecific Antibody-Drug Conjugates (BsADCs)
Degrader-Antibody Conjugates (DACs)
Dual-Payload Antibody–Drug Conjugates
Nanobody-Drug Conjugates (NDCs)
Scaffold-Drug Conjugates (SDCs)
Products
ADC Cytotoxin
Auristatins
Calicheamicins
Camptothecins
Daunorubicins/Doxorubicins
Duocarmycins
Maytansinoids
Piericidins
Pyrrolobenzodiazepines
Traditional Cytotoxic Agents
Other Cytotoxins
ADC Cytotoxin with Linker
ADC Linker
Cleavable Linker
Non-Cleavable Linker
Antibody-Drug Conjugates (ADCs)
Targets
AXL Targets
BCMA Targets
CD19 Targets
CD22 Targets
CD30 Targets
CD33 Targets
CD79b Targets
c-MET Targets
EGFR Targets
FOLR1 Targets
HER2 Targets
Nectin-4 Targets
ROR1 Targets
TF Targets
TROP-2 Targets
Solutions
Early Discovery
Process Development
Preclinical Studies
Resource
Frequently Asked Questions
News
Scientific Corner
Support Documents
Company
Contact Us
About Us
Careers
Inquiry
Support Documents
Home
Resource
Support Documents
Support Documents
Inquiry
Brochures
ADCs Cytotoxin − Auristatins
ADCs Cytotoxin − Calicheamicins
ADCs Cytotoxin − Camptothecins
ADCs Cytotoxin − Doxorubicins
ADCs Cytotoxin − Duocarmycins
ADCs Cytotoxin − Maytansinoids
ADCs Cytotoxin − Pyrrolobenzodiazepines
Flyer
ADC Analysis and Characterization
ADC Conjugation Services
ADC Cytotoxin Development
ADC Development for Targets
ADC Manufacturing Services
Linker Development Services
Posters
The R&D Barriers of Antibody-drug Conjugates
Send Inquiry
-
mg
g
kg
ton
Support Documents
We recommend you to leave us your work email address so that we can serve you better. Please leave your organization information here if you don't have a work email address.
SUBMIT
Inquiry Basket
Loading ......
Delete selected
Go to checkout
